| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.79▲ | 3.79▲ | 3.76▲ | 3.81▼ | 4.14▼ |
| MA10 | 3.79▲ | 3.78▲ | 3.75▲ | 3.92▼ | 4.54▼ |
| MA20 | 3.69▲ | 3.70▲ | 3.77▲ | 4.24▼ | 5.11▼ |
| MA50 | 4.04▼ | 4.15▼ | 4.19▼ | 4.84▼ | 4.65▼ |
| MA100 | 4.29▼ | 4.42▼ | 4.56▼ | 5.27▼ | 94.70▼ |
| MA200 | 4.82▼ | 5.01▼ | 5.22▼ | 4.95▼ | 2,729.34▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.052▲ | 0.055▲ | 0.045▲ | -0.018▼ | 0.550▲ |
| RSI | 54.690▲ | 52.125▲ | 51.147▲ | 39.607▼ | 36.140▼ |
| STOCH | 71.597 | 74.925 | 76.950 | 33.853 | 17.384▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -64.290 | -85.137▼ |
| CCI | 137.116▲ | 143.913▲ | 145.301▲ | -48.326 | -111.555▼ |
| ▲ GAP | $NDRA Open Gap Up %2 | Set Alert |
|
Friday, December 05, 2025 04:00 PM
Fintel reports that on December 8, 2025, Ascendiant Capital maintained coverage of ENDRA Life Sciences (NasdaqCM:NDRA) with a Buy recommendation. As of December 6, 2025, the average one-year price ...
|
|
Monday, November 17, 2025 05:00 AM
ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc. (NDRA) (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer in biomarker imaging technologies for the early detection and monitoring of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/02/26 | 3.99 | 3.99 | 3.76 | 3.80 | 4,508 |
| 06/02/26 | 3.6001 | 4.03 | 3.6001 | 3.89 | 6,240 |
| 05/02/26 | 3.74 | 3.93 | 3.63 | 3.79 | 24,834 |
| 04/02/26 | 3.70 | 3.9336 | 3.3675 | 3.89 | 115,770 |
| 03/02/26 | 3.80 | 3.80 | 3.2501 | 3.68 | 13,619 |
| 02/02/26 | 3.80 | 3.85 | 3.555 | 3.58 | 16,535 |
| 30/01/26 | 3.97 | 4.0474 | 3.80 | 3.80 | 7,989 |
| 29/01/26 | 4.25 | 4.6184 | 4.00 | 4.00 | 19,531 |
| 28/01/26 | 4.39 | 4.57 | 4.25 | 4.56 | 7,074 |
| 27/01/26 | 4.46 | 4.46 | 4.25 | 4.25 | 10,561 |
|
|
||||
|
|
||||
|
|